Spine Surgery

United States

Spine Surgery

United States

Time filter

Source Type

MELBOURNE, FL--(Marketwired - May 9, 2017) -  First Choice Healthcare Solutions, Inc. ( : FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedics and Spine care, today announced that the Company has engaged Marcum LLP ("Marcum") as its new principal independent registered public accounting firm effective May 5, 2017. Headquartered in New York City, Marcum is one of the largest independent public accounting and advisory services firms in the United States. After a thorough search, First Choice's Board of Directors recommended and approved replacing the Company's previous accounting firm RBSM, LLP with Marcum. First Choice had no disagreements or reportable events with its previous accounting firm. Chris Romandetti, President and CEO of First Choice, stated, "First Choice has grown significantly, and with this growth, it was time for the Company to engage a larger firm with a more encompassing range of services. After meeting with several public accounting firms, we are pleased to announce the selection of Marcum as our new independent registered public accounting firm. They are one of the largest firms in the country with extensive experience dealing with public companies. We are confident Marcum will provide the independent accounting and auditing services our Company and Shareholders expect. We are looking forward to working with Marcum in the coming years as we continue our growth." For more information regarding the Company's change in auditing firm, please refer to the Company's Form 8-K filed on May 9, 2017. About First Choice Healthcare Solutions, Inc. Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com. Safe Harbor Statement Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.


MELBOURNE, FL--(Marketwired - May 12, 2017) - First Choice Healthcare Solutions, Inc. ( : FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopedics and spine care, announced today it will release financial results for the three months ended March 31, 2017, on Monday, May 15, 2017 after the market close. First Choice will follow this announcement with a conference call and webcast for the investment community on Tuesday, May 16, 2017 beginning at 11:00 AM Eastern Time to discuss the results and recent corporate developments. Chris Romandetti, Chairman, President and CEO of First Choice, and Tim Skeldon, CFO, will host the call. Participants can register and access the conference call by dialing toll-free 866-682-6100 (for U.S. and Canada dial-in) or 862-255-5401 (for international dial-in). The conference call will also be webcasted, which can be accessed through First Choice's investor relations website by navigating to http://ir.myfchs.com/ and clicking on "First Quarter 2017 Conference Call and Webcast." Participants will be required to register to access the call. For those who cannot listen to the live broadcast, a replay will be available shortly after the call on the investor relations page of First Choice's website, found at http://ir.myfchs.com/. About First Choice Healthcare Solutions, Inc. Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com. Safe Harbor Statement Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.


NEW YORK, May 11, 2017 /PRNewswire/ -- Spine-related disorders and deformities are treated using motion preservation devices. Disorders such as spinal stenosis and lumbar degenerative spondylolisthesis are caused due to the degeneration of intervertebral disc, deformity, tumors, and trauma. Implant systems equipped with specially designed spinal instrumentation such as plates, rods, and screws, which are used for fusion, correct deformities, and stabilize & strengthen the spine, are used in motion preservation surgical procedures. Read the full report: http://www.reportlinker.com/p04805981/Motion-Preservation-Devices-Market-by-Product-and-Surgery-Global-Opportunity-Analysis-and-Industry-Forecast.html The motion preservation devices market generated $920 million in 2015, and is projected to reach $1,902 million by 2022, registering a CAGR of 10.9% from 2016 to 2022. The market is driven by factors such as increase in geriatric population, rise in incidence of spinal disorders, and growth in patient awareness about advances in spinal surgeries, such as artificial disc replacement. However, unfavorable reimbursement scenario and stringent regulatory approval procedure hamper the market growth. The report segments the motion preservation devices market based on product type, surgery, and region. According to the product type, it is segmented into dynamic stabilization devices, artificial disc replacement devices, annulus repair devices, and nuclear disc prostheses devices. Based on the type of surgery, the market is segmented into open spine surgery and minimally invasive spine surgery. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA. The key market players have adopted product development strategies such as product launches, approvals, and clinical trials. For instance, in September 2012, Globus Medical, Inc. received FDA approval for SECURE-C Artificial Cervical Disc, which is used to replace the diseased cervical disc causing arm pain and/or weakness or numbness. KEY BENEFITS FOR STAKEHOLDERS This report offers an extensive analysis of the current trends and emerging estimations of the global motion preservation market for the period of 2014–2022 to identify the prevailing opportunities. Comprehensive analysis of geographical regions is provided along with the factors that drive and restrict the market growth. Quantitative analysis of the market for the period of 2014–2022 is provided to understand the financial scenario. The regional and country-level analyses of the market are provided in the report. MOTION PRESERVATION DEVICES MARKET KEY SEGMENTS By Product Type Motion Preservation Devices Dynamic Stabilization Devices Interspinous Process Spacers Pedicle Screw-based Systems Facet Replacement Products Artificial Discs Artificial Cervical Discs Artificial Lumbar Discs Annulus Repair Devices Nuclear Disc Prostheses By Surgery Open Spine Surgery Minimally Invasive Spine Surgery By Region North America U.S. Canada Mexico Europe France Germany UK Spain Italy Rest of Europe Asia-Pacific India China Japan South Korea Australia Rest of Asia-Pacific LAMEA Brazil Saudi Arabia South Africa Read the full report: http://www.reportlinker.com/p04805981/Motion-Preservation-Devices-Market-by-Product-and-Surgery-Global-Opportunity-Analysis-and-Industry-Forecast.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/motion-preservation-devices-market-by-product-and-surgery-global-opportunity-analysis-and-industry-forecast-2014-2022-300456342.html


News Article | May 16, 2017
Site: www.prweb.com

At the 10th Annual Congress of the Chinese Association of Orthopaedic Surgeons (CAOS), long-standing development partners Invibio Biomaterial Solutions, UK, and China’s Double Medical Technology Inc. ("Double Medical") collaborated on an interbody spine surgery workshop to help expand knowledge of the implantation of Double Medical’s Direct Lateral Interbody Fusion (DLIF) spinal cages made with PEEK-OPTIMA™. The biomaterial PEEK-OPTIMA polymer by Invibio was introduced to medical device manufacturers in China after the approval by the China Federal Drug Administration (CFDA) in 2004. Hosted in conjunction with the North American Spine Society (NASS), the CAOS workshop “Principles and Techniques of Complex Spine Surgery Workshop” took place on May 12, 2017, at the Zhongshan School of Medicine, Sun Yat-sen University, in Guangzhou. The event was the fifth joint NASS-CAOS workshop and delivered a full day of hands-on cadaver labs with over one hundred surgeons attending and multiple one-hour product demonstrations streamed live to the audience, including the demonstration of Double Medical and medical-grade PEEK innovator Invibio. Double Medical, a large medical equipment group whose broad product range includes orthopaedic implants, dental implants, general surgical products, neurosurgical products and electronic medical devices, and Invibio have been working together since 2009. At this jointly planned NASS-CAOS event, the two companies demonstrated a Direct Lateral Interbody Fusion (DLIF) spinal cage made with PEEK-OPTIMA and showed how the DLIF cage, which has already been used in lumbar surgeries, can provide a better overall therapeutic experience for patients. "The design of this innovative DLIF cage incorporates advances in medical technology contributed by both our companies," commented Michael Veldman, global strategic marketing manager at Invibio. During the NASS-CAOS workshop he delivered a short introduction on PEEK-OPTIMA, its potential clinical benefits and outlined how the adoption of the new PEEK-OPTIMA HA Enhanced is progressing, both globally and within China. Veldman said, “It is important to note that advanced surgical technique now allows the placement of the DLIF Cage across the disc space, while avoiding the anterior vessels, and the posterior neural and bony elements. As well, the bullet-nose design allows for ease of insertion, while autogenous bone graft or bone graft substitute are accommodated, allowing fusion to occur through the cage. This is a remarkable design. It's innovation in action." Double Medical is driving progress based on Invibio's implantable biocompatible polymers into China and globally. Double Medical´s orthopaedic implants are a leading product in the domestic market in China, and the company has branches in more than 30 of China's provinces and cities. Double Medical is also cooperating with more than 3,500 hospitals and nearly 1,000 business enterprises in China; its products have been exported to more than 40 countries and regions that include the US, EU, Russia, Southeast Asia, Middle East and South Africa. "At Double Medical it is our professional goal, as a specialist in medical products, to be in the top three of the industry in China," said Jack Zhu, Sales Director at Double Medical's Spine Business Unit. The company is one of the key high-tech enterprises of China's National Torch Plan.* "We will do this by implementing a strategy to diversify our products for the medical field, to become a comprehensive supplier of high-value, high-quality medical materials. The cooperation with Invibio, over a number of years, is central to that policy, where innovation is key. With Invibio, we have been able to launch innovative medical products and build an innovation-driven enterprise." Worldwide, the number of implanted medical devices that incorporate PEEK-OPTIMA polymer has increased to around nine million. Invibio is building on this pioneering success, working within China's flourishing and advanced medical sector, where enhanced therapeutic technologies and techniques are being prioritised by official government policy. Developed by Invibio, a leading provider of biomaterial solutions, PEEK-OPTIMA polymer solutions are widely recognized for spinal interbody fusion and are frequently used in medical applications. The innovative material offers a variety of clinical advantages including a modulus close to that of human bone, reduced stress shielding and, in contrast to metals, artifact-free imaging that allows for clear fusion assessment. For further information please visit https://invibio.com/spine. About Double Medical Technology Inc. Founded in 2004, Double Medical Technology Inc. is one of the key high-tech enterprises listed on the National Torch Plan and today a large medical equipment group. The broad product portfolio includes orthopaedic implants, dental implants, general surgery products, neurosurgery products, medical electronic devices. Double Medical´s orthopaedic implants are a leader in the domestic market in China. The company has branches in over 30 provinces and cities and is cooperating with more than 3,500 hospitals and nearly 1,000 business enterprises in China; its products have been exported to more than 40 countries and regions that include the US, EU, Russia, Southeast Asia, Middle East and South Africa. For more information, please visit http://www.double-medical.com/en About Invibio Biomaterial Solutions Invibio, a Victrex plc company, is a global leader in providing high performance biomaterial solutions to medical device manufacturers. The company provides PEEK-OPTIMA™ polymers, advanced technical research and support, and manufacturing of components for spine, trauma and orthopaedic medical segments for the development of long-term implantable medical devices. Today, Invibio’s PEEK-OPTIMA™ polymers are used in ~9 million implanted devices worldwide. For more information, please visit https://invibio.com/ INVIBIO™, PEEK-OPTIMA™, INVIBIO BIOMATERIAL SOLUTIONS™ are trademarks of Victrex plc or its group companies. All rights reserved. About Victrex plc Victrex is an innovative world leader in high performance polymer solutions, focussed on the strategic markets of automotive, aerospace, energy, electronics and medical. Every day, millions of people use products and applications, which contain our materials – from smart phones, aeroplanes and cars to oil and gas operations and medical devices. With over 35 years’ experience, we develop world leading solutions in PEEK and PAEK-based polymers, semi-finished and finished parts, which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at http://www.victrex.com


Orlando, FL and Houston, TX, May 18, 2017 (GLOBE NEWSWIRE) -- Mazor Robotics, a pioneer and leader in the field of surgical guidance systems, announced that a Mazor X system was installed at Houston Methodist Hospital in Texas on April 20, 2017. Dr. Paul Holman, Neurosurgeon and Clinic Director of Spine Surgery at Houston Methodist Hospital, performed the first procedure earlier this month. Houston Methodist consists of seven hospitals in the Greater Houston metropolitan area and is one of the nation’s leading health systems and academic medical centers with physician-scientists working on more than 800 clinical trials. In addition to advancing medicine and treatments, the health system’s dedication to exceptional patient care is clear after being named the No. 1 hospital in Texas for the fifth year in a row by U.S. News & World Report. “Houston Methodist is a world-renowned health system providing top-level patient care and we are honored that they have chosen the Mazor X system for their spine surgery program,” said Mazor Robotics, Inc. CEO Christopher Prentice. “The Mazor X system was designed to better utilize clinical diagnostics and data in order to assist in the improvement of spine surgery, and with a leading academic institution such as Houston Methodist involved, we look forward to this possibility.” Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance Systems enable surgeons to conduct spine and brain procedures in an accurate and secure manner. For more information, please visit MazorRobotics.com. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8f655dca-34c1-4b99-839a-f51f2a6309f6


MELBOURNE, FL--(Marketwired - May 17, 2017) - First Choice Healthcare Solutions, Inc. ( : FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedics and spine care, today announced that the Company has engaged international IR specialists MZ Group to lead a new strategic investor relations and financial communications program. First Choice welcomes its partnership with MZ Group, the largest independent IR firm in the world. Over the course of the next several weeks, MZ Group will work closely with First Choice management to develop and execute a comprehensive capital markets strategy designed to increase the company's visibility amongst investors. This structured campaign will be augmented by the company's recent business success, evidenced by the rapidly growing Average Patient Value (APV) and accompanying revenue growth. First Choice provides a fully integrated, non-physician-owned, healthcare delivery platform. The clear value proposition, which guides patients through all facets of care, while allowing doctors to free themselves from the hassle of private practice administration, has been a key driver behind the continued revenue growth. President of MZ Group North America, Ted Haberfield commented, "MZ Group is excited to have the opportunity to partner with a healthcare visionary like First Choice. After completing comprehensive due diligence, we're convinced that First Choice is at an inflection point regarding market awareness, market traction, and market share growth. First Choice provides a clear value proposition to both its patients and its world class team of providers. This profitable, scalable growth trajectory creates a compelling story to share with the investment community. We are proud to be working with First Choice and feel the company fits well into our portfolio of partner companies." "Taking both our continued growth and future catalysts into account, we are now ready to engage U.S. investors and have decided to partner with MZ Group to expand and strengthen our investor relations program," said First Choice Chairman, President and CEO, Chris Romandetti. "MZ Group provides the reach and established track record we need to develop relationships with the retail and institutional investors who are seeking quality companies with notable growth potential. We're confident that as we continue to execute upon our growth plans, we can create substantial value for our shareholders." About First Choice Healthcare Solutions, Inc. Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com. About MZ Group MZ, founded in 1999, combines capital markets intelligence, global investor targeting, IR technology, corporate governance, media and corporate communication and IR consulting, providing comprehensive programs that successfully build and manage shareholder value. With a team of highly experienced senior professionals and an integrated service portfolio, MZ ensures that companies are provided with the right tools and strategies to interact effectively with the investment community and the media, successfully conveying the investment message. MZ's market intelligence, advisory and tactical support activities for investor relations and corporate communications programs are underpinned by a comprehensive IT infrastructure, allowing companies to rapidly achieve global standards of best practices. For more information, please visit www.mzgroup.us. Safe Harbor Statement Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.


HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, is pleased to announce the approval of the study to help determine outcomes for Open vs. Minimally Invasive Posterior Lumbar Spine Surgery. The purpose of this study is to determine which procedure, open PLIF or MIDLIF, using Life Spine’s NAUTILUS® Thoracolumbar Pedicle Screw System and CENTERLINE® Thoracolumbar Cortical Screw System hardware, is less traumatic to the patient, produces better functional outcomes, and to evaluate if a patient type is better suited for a particular surgery. The goal of this study is to better quantify the approach and outcomes by demonstrating muscular injury and recovery by comparing a baseline pre-operative EFA (Electrodiagnostic Functional Assessment) to post-operative EFA tests obtained at specified times, and thus comparing two surgical techniques to determine which demonstrates faster muscular recovery and better functional outcomes. “This study is unique because for the first time ever, in addition to using questionnaires, surgical outcomes are being assessed by the EFA which measures soft tissue, muscular injury, and recovery. To date there is substantial expense for ongoing treatment and narcotic use to control pain. Under these complicated circumstances medical providers are challenged to find treatments that are less invasive and traumatic that lead to quicker and better recovery time,” said Frank Tomecek, MD FAANS, Principle Investigator. MaryRose Reaston, Ph.D. CSO Founder Emerge Diagnostic and a Co-Investigator, said, “We are pleased to take part in a ground breaking research study by being able to document muscle pathology and improve patient care.” “The study provides a comparative platform to help determine which technique demonstrates faster muscular recovery and better functional outcomes. This is an exciting opportunity for use of both Life Spine’s cortical bone screw and traditional pedicle screw systems,” said Mariusz Knap, Vice President of Marketing for Life Spine. “We continue to focus on advancements that strive to improve surgical efficiencies, ease of use and reliability of PLIF and MIDLINE systems, thus providing the highest value of care to our customers and patients.” Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com. Headquartered in Carlsbad, CA Emerge Diagnostics is delivering a new way to determine the location and age of soft tissue injuries. The Company provides comprehensive technology and Emerge is leading the way with technological development and ongoing innovation to improve patient outcomes and provide better care. For more information, visit emergedx.com. Oklahoma Spine and Brain is a Tulsa, OK based neurosurgery group focused on care of the spine and brain. Oklahoma Spine & Brain Institute is a private practice neurosurgical group, dedicated to delivering the highest quality neurosurgical (spine and brain) care possible. We provide this level of care through compassion, technology, education and quality neurosurgical health care to each person we serve. By concentrating on our special areas of interest and expertise, we can fulfill our goal of becoming the leading provider of neurosurgical services in northeast Oklahoma. In this age of "Managed Care", we always place quality of care above cost considerations. We pay close attention to patient confidentiality. Our physicians are some of the most experienced, well-trained neurosurgeons in this part of the country. http://www.oksbi.com/


News Article | May 25, 2017
Site: www.prweb.com

The conference, taking place June 22-24, 2017 at the Swissotel in Chicago, IL is expected to bring together over 1,100 ASC thought leaders to discuss topics such as improving profits, managed care contracting, orthopedics, marketing, practice issues, quality, infection control, pain management, anesthesia, medical devices and more. The event will feature the following keynote speakers: Chairman & Chief Executive Officer, Surgical Care Affiliates, Andrew Hayek Chief Executive Officer, DuPage Medical Group, Michael A Kasper Desert Institute of Spine Care, Voluntary Professor, Department of Neurosurgery, University of New Mexico School of Medicine, Anthony Yeung, MD Founder, President and Neurosurgeon, NeoSpine, Richard Wohns, MD, JD Spinal Neurosurgeon and Founder/Chairman, SpineNevada, James J. Lynch, MD, FAANS Director, Division of Spine Surgery, Professor, Orthopaedic Surgery, Rush University Medical Center, Frank M. Phillips, MD Former NFL Running Back, Los Angeles Raiders and the Kansas City Chiefs and Analyst, CBS, Marcus Allen Business and Financial News Legend and Host, Fox Business News' Lou Dobbs Tonight, Lou Dobbs Thank you to the conference sponsors: ​Back Pain Centers of America CollectRx Contego Solutions CoreLink DePuy Synthes ECG Management eClinicalWorks Haag STREIT USA HealthCare Appraisers, Inc. LifeSpine Live Oak Bank McKesson Medical Surgical Medline Industries, Inc. Medtronic Meridian Surgical Partners North American Partners in Anesthesia National Medical Billing Services OM1 Paradigm Spine Regent Smith & Nephew Surgial Information Systems Surgical Care Affiliates Surgical Notes United Surgical Partners International Xenco Medical Zero Gravity 1st Providers Choice AAAHC Amgen ASCOA ASCs Inc. ASD Management (Should be the sessi​​ons starting at 1:05 pm) Astura Medical Augustine Temperature Management AxioMed Bankers Healthcare Group BBL Medical Facilities Bolder Healthcare Solutions Cardinal Health Catalyst Partners Centinel CONMED Convergent Ortho Corentec CyraMedX Doctor.com Esaote Experior Healthcare Systems GE Healthcare Global Medical REIT HSTpathways in2itive Business Solutions Institute for Medical Quality Integrity Implants KARL STORZ Endoscopy Lee Medical Lockard Construction MDClarity MedHQ MediGain Practice Management Meditech Spine Medtek National Healthcare Development Natural Scientific Solutions (aka Lenova) NuVasive OJM Group Ortech Data Inc Orthofix PharMEDium PhyBus Physician Partners of America Practice Partners in Healthcare, LLC Providence Medical Technology Provista Purdue Pharma L.P. Rational Surgical Solutions Safe Passage Neuromonitoring Sage Products SeaSpine Shukla Medical SI-Bone Spinal Elements, Inc Spine Wave Spineology Steribite Surgery Partners The Coding Network Vertiflex Wells Fargo Equipment Finance Wenzel Spine

Loading Spine Surgery collaborators
Loading Spine Surgery collaborators